Industries · Drug Discovery & Biotechnology
OMICS4 runs the wet-lab side of discovery programmes: mechanism-of-action transcriptomics, targeted quantification across screening series, and protein-level confirmation, bookable end to end.
Platforms used in this field
Platforms
Nucleic acid and protein recovery from cultured and treated material.
Sequencing and targeted quantification on the same material.
Protein-level confirmation of a transcript result.
Cell lines, treated cultures, animal tissue, plasma and extracted nucleic acid. Input and quality criteria are published per sample type. Plate-format submissions are supported for screening series, with the plate map carried through to the result tables.
A QC report for every sample. Demultiplexed FASTQ with run-level QC metrics for the sequencing services. Result tables for PCR and protein work. Turnaround published per service.
Alignment, quantification, integration, biomarker discovery and modelling are not part of a platform booking. They are run by GenXMap's R&D team, as the Mechanism of Action Package, a programme designed for your industry rather than a line on a quote. Ask for it in the quote request and both are scoped together.
Mechanism of Action Package at GenXMapHave a project in this space?